1. Pharmacological Mechanisms and Clinical Applications of Curcumin: Update
   Min Hao et al, 2023, Aging and disease CrossRef
2. The Role of Actin Dynamics and Actin-Binding Proteins Expression in Epithelial-to-Mesenchymal Transition and Its Association with Cancer Progression and Evaluation of Possible Therapeutic Targets
   Magdalena Izdebska et al, 2018, BioMed Research International CrossRef
3. Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma
   Hongjin Chen et al, 2021, Frontiers in Oncology CrossRef
4. Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis
   Arpita Datta et al, 2021, Cancers CrossRef
5. Role of a small GTPase Cdc42 in aging and age-related diseases
   Bauyrzhan Umbayev et al, 2023, Biogerontology CrossRef
6. Nanoscale Formulations: Incorporating Curcumin into Combination Strategies for the Treatment of Lung Cancer
   Quhui Wu et al, 2021, Drug Design, Development and Therapy CrossRef
7. Unraveling the Anticancer Effect of Curcumin and Resveratrol
   Aline Pavan et al, 2016, Nutrients CrossRef
8. Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design
   Zdeněk Kejík et al, 2021, Pharmaceutics CrossRef
9. Regulating Cdc42 and Its Signaling Pathways in Cancer: Small Molecules and MicroRNA as New Treatment Candidates
   Xing-Hua Xiao et al, 2018, Molecules CrossRef
10. Multiple Actions of Curcumin Including Anticancer, Anti-Inflammatory, Antimicrobial and Enhancement via Cyclodextrin
    Aaron J. Smith et al, 2015, Journal of Cancer Therapy CrossRef
11. Inhibition of Cdc42–intersectin interaction by small molecule ZCL367 impedes cancer cell cycle progression, proliferation, migration, and tumor growth
    Byron J. Aguilar et al, 2019, Cancer Biology & Therapy CrossRef
12. Mechanistic Understanding of Curcumin’s Therapeutic Effects in Lung Cancer
    Wan Nur Baitty Wan Mohd Tajuddin et al, 2019, Nutrients CrossRef
13. The Molecular Targets and Anti-Invasive Effects of 2,6-bis-(4-hydroxyl-3methoxybenzylidine) cyclohexanone or BHMC in MDA-MB-231 Human Breast Cancer Cells
    Siti Harun et al, 2018, Molecules CrossRef